Variation in the mannose binding lectin (MBL) gene and susceptibility to sepsis

Sepsis

Volumn 4, Issue 3, 2001, Pages 201-207

  Hibberd, Martin L ^a   Summerfield, John A ^a   Levin, Michael ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Genetic susceptibility; Mannose binding lectin

Indexed keywords

LECTIN; MANNOSE BINDING PROTEIN;

ALLELISM; ANTIBODY PRODUCTION; COMPLEMENT ALTERNATIVE PATHWAY; DNA POLYMORPHISM; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MOLECULAR DYNAMICS; PREVALENCE; REVIEW; SEPSIS;

EID: 0035655557     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012960906764     Document Type: Review

References (73)

1. Phylogenetic perspectives in innate immunity
2. The instructive role of innate immunity in the acquired immune response
3. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
4. Seeking Wisdom in innate immunity
5. Innate immunity
6. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors
7. Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity
8. The serum mannosebinding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity
9. Protein proves to be a key link in innate immunity
10. The complement system and adaptive immunity
11. Infectious diseases associated with complement deficiencies
12. Complement deficiency states and infection: Epidemiology, Pathogenesis and consequences of Neisserial and other infections in an immune deficiency
13. Killing of Neisseria meningitidis by human neutrophils: Implications for normal and complement-deficient individuals
14. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B
15. Molecular mechanisms of innate immunity
16. Pathophysiologic basis of sepsis: Considerations for future strategies of intervention
17. Targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock
18. The role of the complement cascade in sepsis
19. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups
20. Regulation of the complement membrane attack pathway
21. Mannose-binding lectin: The pluripotent molecule of the innate immune system
22. A second serine protease associated with mannan-binding lectin that activates complement
23. Improvements on the purification of mannan-binding lectin and demonstration of its Ca2+ independent association with a C1s-like serine protease
24. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein
25. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease
26. Lysis via the lectin pathway of complement activation: Minireview and lectin pathway enhancement of endotoxininitiated hemolysis
27. Familial properdin deficiency and fatal meningoccaemia. Correction of the bactericidal defect by vaccination
28. Properdin deficiency: Molecular basis and disease association
29. The lipopolysaccharide structures of Salmonella enterica serovar Typhimurium and Neisseria gonorrhoeae determine the attachment of human mannosebinding lectin to intact organisms
30. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition
31. MASP1 (MBL-associated serine protease 1)
32. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway
33. Mannose binding protein is involved in first-line host defence: Evidence from transgenic mice
34. C3d of complement as a molecular adjuvent: Bridging innate and aquired immunity
35. Collectins-soluble proteins containing collagenous regions and lectin domains-and their roles in innate immunity
36. The human mannose-binding protein functions as an opsonin
37. Human mannose-binding protein functions as an opsonin for influenza A viruses
38. Complement receptor 1/CD35 is a receptor for mannan-binding lectin
39. Human leukocyte C1q receptor binds other soluble proteins with collagen domains
40. A familial, plasma-associated defect of phagocytosis: A new cause of recurrent bacterial infections
41. Defective opsonization. A common immunity deficiency
42. Yeast opsonisation in children with chronic diarrhoel states
43. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein
44. Association of low levels of mannan-binding protein with a common defect of opsonization
45. Serum lectin with known structure activates complement through the classical pathway
46. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein
47. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease
48. Proteolytic activities of two types of mannose-binding lectin-associated serine protease
49. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2
50. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein
51. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene
52. Molecular basis of opsonic defect in immunodeficient children
53. Distinct and overlapping functions of allelic forms of human mannose binding protein
54. Role of the collagen-like domain of the human serum mannan-binding protein in the activation of complement and the secretion of this lectin
55. Distint physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype
56. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein
57. A human mannosebinding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins
58. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response
59. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein
60. Mannosebinding lectin alleles in a prospectively recruited UK population
61. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series
62. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease
63. Association of familial deficiency of mannose-binding lectin and meningococcal disease
64. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans
65. Mannose-binding protein B allele confers protection against tuberculous meningitis
66. Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India
67. Association of mannosebinding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis
68. Distinct physico-chemical characteristics of human mannose binding protein (MBP) expressed by individuals of differing genotype
69. Association of low levels of mannan-binding protein with a common defect of opsonisation
70. Increased frequency of homozygosity of abnormal mannan-bindingprotein alleles in patients with suspected immunodeficiency
71. Mannose binding protein gene mutations associated with unusual and severe infections in adults
72. Diallelic polymorphism may explain variations of the blood concentrations of mannan-binding protein in Eskimos, but not in black Africans
73. Mutations in the human mannose-binding protein gene: Frequencies in several population groups